Ascentage Pharma Group Intl ADR (AAPG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 06-2025 | 12-2024 | 06-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 353,217 | 231,930 | 172,785 | 151,408 | 150,516 |
| Receivables | 36,170 | 10,939 | 11,390 | 102,312 | 20,076 |
| Inventories | 4,092 | 1,199 | 904 | 1,475 | 2,225 |
| Other current assets | 27,532 | 0 | 16,880 | 15,038 | 12,148 |
| TOTAL | $421,011 | $266,447 | $201,959 | $270,233 | $184,965 |
| Non-Current Assets | |||||
| PPE Net | N/A | 114,635 | 148,961 | N/A | 146,980 |
| Investments And Advances | 5,295 | 5,212 | 4,638 | 4,569 | 2,607 |
| Intangibles | 0 | 13,357 | 0 | 0 | 0 |
| Other Non-Current Assets | 21,924 | 25,574 | 27,980 | 24,610 | 24,796 |
| TOTAL | $27,219 | $158,778 | $181,579 | $29,179 | $174,383 |
| Total Assets | $566,784 | $425,225 | $358,638 | $427,547 | $344,065 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 174,812 | 116,392 | 106,731 | 100,388 | 84,820 |
| Accounts payable and accrued liabilities | 15,264 | 51,375 | 12,599 | 11,433 | 9,969 |
| Other current liabilities | 44,923 | 5,233 | 40,495 | 34,776 | 33,757 |
| TOTAL | $234,999 | $173,000 | $159,825 | $146,597 | $128,546 |
| Non-Current Liabilities | |||||
| Long Term Debt | 108,284 | 123,176 | 121,852 | 133,553 | 162,262 |
| Other Non-Current Liabilities | 31,782 | 33,789 | 34,899 | 34,707 | 37,083 |
| TOTAL | $140,995 | $157,872 | $161,253 | $174,108 | $205,800 |
| Total Liabilities | $375,994 | $330,872 | $321,078 | $320,705 | $334,346 |
| Shareholders' Equity | |||||
| Common Shares | 37 | 33 | 29 | 29 | 27 |
| Retained earnings | -1,002,892 | -888,006 | -790,563 | -715,835 | -738,265 |
| Other shareholders' equity | -24,638 | -16,760 | -15,907 | -16,338 | -16,837 |
| TOTAL | $190,790 | $94,353 | $37,560 | $106,842 | $9,719 |
| Total Liabilities And Equity | $566,784 | $425,225 | $358,638 | $427,547 | $344,065 |